FCN-159 Monotherapy Versus Chemotherapy by Investigator's Choice in Pediatric Low-grade Glioma Patients With BRAF Alteration
Clinical trial NCT07004075 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07004075
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-30
- Primary completion
- 2027-04-30
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.